published meta-analysis   sensitivity analysis   studies

Non replicating viral vector in COVID-19 prophylaxis (excluding children) - Summary of results

OutcomeTE95% CInkI2ROBPub. bias confirmed COVID (any severity)detailed resultsKislaya, 2022 0.36 [0.20; 0.64] 0.36[0.20; 0.64]Kislaya, 202210%NAnot evaluable0.22.01.0relative treatment effectwww.metaEvidence.org2024-06-26 16:27 +02:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 89 - treatments: 821,1288,1287,1286,760,1284,802,765,1285,759 - roots T: 290